查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2028 年雌激素和黃體酮市場
市場調查報告書
商品編碼
1215662

2022-2028 年雌激素和黃體酮市場

Estrogen and Progesterone Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 | 商品交期: 2-3個工作天內

價格

在預測期內，全球雌激素和黃體酮市場預計將以 14.1% 的複合年增長率顯著增長。 天然有機激素平衡藥物的增長趨勢正在為市場發展創造新的機遇。 以黃體酮為基礎的天然產品包含在由大豆或墨西哥野生、不可食用的山藥（稱為 Dioscorea villosa）製成的組合藥物中。 Crinone 和 Prometrium 是市場上最好的天然黃體酮藥物。 該報告進一步分析了直接或間接影響市場增長的所有主要和次要因素。

全球雌激素和黃體酮市場根據類型和分銷渠道進行細分。 根據類型，市場分為阿格司酮、米非司酮、asoprisnil、terapristone、ulipristal acetate。 銷售渠道細分為藥店、醫院和診所。 在這些分銷渠道中，醫院佔據了很大的市場份額，因為它們是消費者最信任的購買藥品的地方。 然而，非處方藥的增長趨勢和藥店提供的誘人折扣將顯著推動藥店市場。 以上細分也可以根據您的要求定制。

從地域上看，全球雌激素和黃體酮市場分為北美、歐洲、亞太地區和世界其他地區。 我們還可以應要求提供特定地區或國家層面的市場分析。 大多數國家，包括阿聯酋和沙特阿拉伯，都禁止變性手術。 性別不安患者只有在獲得政府醫療委員會的批准後才能接受變性治療或手術。 據海灣新聞報導，過去 36 年來，約有 2,000 名沙特人接受了變性手術。 這些政府法規對雌激素和孕激素市場產生了多重影響。

內容

第 1 章報告概述

  • 當前行業分析和增長前景
  • COVID-19 對全球雌激素和黃體酮市場的影響
  • 雌激素和孕激素全球市場復甦情景
  • 研究方法和工具
  • 市場細分
    • 按細分
    • 按地區

第 2 章市場概述和洞察

  • 調查範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 推薦
    • 總結

第三章競爭格局

  • 主要公司分析
    • 阿斯利康有限公司
    • 梯瓦製藥工業有限公司
    • Abbott Healthcare Products B.V.
    • 諾華國際公司
  • 關鍵策略分析

第四章市場細分

  • 全球雌激素和黃體酮市場：按類型分類
    • 阿格立斯頓
    • 米非司酮
    • 阿索普尼
    • 泰拉普利斯頓
    • 醋酸烏利司他
  • 全球雌激素和黃體酮市場：按分銷渠道
    • 藥房
    • 醫院和診所

第五章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他亞太地區
  • 世界其他地方

第六章公司簡介

  • Aspen Pharmacare Australia Pty Ltd.
  • Bayer AG
  • Besins Healthcare Benelux
  • Bluebell pharma Group Co.
  • Dr.Kade Pharmazeutische Fabrik GmbH
  • Eli Lilly Nederland B.V.
  • F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A.
  • Gedeon Richter Plc
  • Jenapharm GmbH & Co. KG
  • MERCK SERONO, Ltd.
  • N.V.Organon
  • Orion Corp.
  • Pfizer, Inc.
  • Shanghai Yijing Industrial Co., Ltd.
  • Sofgen Pharmaceuticals
  • Virtus Pharmaceuticals LLC
Product Code: OMR2026718

Title:Global Estrogen and Progesterone Market Size, Share, and Trends Analysis Report by Type (Aglepristone, Mifepristone, Asoprisnil, Telapristone, and Ulipristal Acetate) and By Distribution Channel (Pharmacy and Hospital and Clinics), Forecast Period (2022-2028).

The global estrogen and progesterone market is anticipated to grow at a considerable CAGR of 14.1% during the forecast period. The rising trend of natural and organic hormone balancing drugs is generating new opportunities for market development. Natural progesterone-based products are inclusive of combination drug therapies made from soybeans or a wild, inedible Mexican yam called Dioscorea villosa. Crinone and Prometrium are the most natural progesterone drugs in the market. This report will further analyze all the primary as well as secondary factors that are directly or indirectly impacting the growth of the market.

The global estrogen and progesterone market is segmented based on the type and distribution channel. Based on the type, the market is segmented into aglepristone, mifepristone, asoprisnil, telapristone, and ulipristal acetate. Based on the distribution channel, the market is sub-segmented into pharmacy, and hospital and clinics. Among these distribution channels, the hospital segment holds the major share in the market as it is the most trusted source for drug purchases among consumers. However, the rising trend of OTC drugs and attractive discounts offered by pharmacies will significantly drive the pharmacy segment in the market. The above-mentioned segments can also be customized as per the requirements.

Geographically, the global estrogen and progesterone market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The market can also be analyzed for a particular region or country level as per the requirement. Most nations, including the UAE and Saudi Arabia, had banned sex-change surgeries. Patients with gender dysphoria can only undergo sex correction therapies or surgeries if they get approval from the governmental medical commission. As per the Gulf News, around 2,000 Saudis had undergone sex correction surgeries in the past 36 years. Such government regulations have a mixed impact on the estrogen and progesterone market.

The major companies serving the global estrogen and progesterone market include AstraZeneca Ltd., Teva Pharmaceutical Industries Ltd., Abbott Healthcare Products B.V., Novartis International AG, Pfizer Inc., Merck Serono Ltd., and Bayer AG, among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, Bayer AG announced the acquisition of KanDy Therapeutics Inc. in August 2020, which aids in the expansion of Bayer's women's drug pipeline by adding KanDy's menopause drug to its portfolio.

Research Methodology

The market study of the global estrogen and progesterone market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global Estrogen and Progesterone Market Research and Analysis by Type.
  • Global Estrogen and Progesterone Market Research and Analysis by Distribution Channel.

The Report Covers:

  • Comprehensive research methodology of the global estrogen and progesterone market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global estrogen and progesterone market.
  • Insights about market determinants that are stimulating the global estrogen and progesterone market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Estrogen and Progesterone Market
  • Recovery Scenario of Global Estrogen and Progesterone Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. AstraZeneca, Ltd.
      • 3.1.1.1. Overview
      • 3.1.1.2. Financial Analysis
      • 3.1.1.3. SWOT Analysis
      • 3.1.1.4. Recent Developments
    • 3.1.2. Teva Pharmaceutical Industries, Ltd.
      • 3.1.2.1. Overview
      • 3.1.2.2. Financial Analysis
      • 3.1.2.3. SWOT Analysis
      • 3.1.2.4. Recent Developments
    • 3.1.3. Abbott Healthcare Products B.V.
      • 3.1.3.1. Overview
      • 3.1.3.2. Financial Analysis
      • 3.1.3.3. SWOT Analysis
      • 3.1.3.4. Recent Developments
    • 3.1.4. Novartis International AG
      • 3.1.4.1. Overview
      • 3.1.4.2. Financial Analysis
      • 3.1.4.3. SWOT Analysis
      • 3.1.4.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Estrogen and Progesterone Market by Type
    • 4.1.1. Aglepristone
    • 4.1.2. Mifepristone
    • 4.1.3. Asoprisnil
    • 4.1.4. Telapristone
    • 4.1.5. Ulipristal Acetate
  • 4.2. Global Estrogen and Progesterone Market by Distribution Channel
    • 4.2.1. Pharmacy
    • 4.2.2. Hospital and Clinics

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. US
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Aspen Pharmacare Australia Pty Ltd.
  • 6.2. Bayer AG
  • 6.3. Besins Healthcare Benelux
  • 6.4. Bluebell pharma Group Co.
  • 6.5. Dr.Kade Pharmazeutische Fabrik GmbH
  • 6.6. Eli Lilly Nederland B.V.
  • 6.7. F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A.
  • 6.8. Gedeon Richter Plc
  • 6.9. Jenapharm GmbH & Co. KG
  • 6.10. MERCK SERONO, Ltd.
  • 6.11. N.V.Organon
  • 6.12. Orion Corp.
  • 6.13. Pfizer, Inc.
  • 6.14. Shanghai Yijing Industrial Co., Ltd.
  • 6.15. Sofgen Pharmaceuticals
  • 6.16. Virtus Pharmaceuticals LLC

LIST OF TABLES

  • 1. GLOBAL ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL AGLEPRISTONE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL MIFEPRISTONE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL ASOPRISNIL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL TELAPRISTONE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL ULIPRISTAL ACETATE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 8. GLOBAL ESTROGEN AND PROGESTERONE MARKET VIA PHARMACY RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL ESTROGEN AND PROGESTERONE MARKET VIA HOSPITAL AND CLINICS RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 12. NORTH AMERICAN ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 13. NORTH AMERICAN ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 14. NORTH AMERICAN ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 15. EUROPEAN ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 16. EUROPEAN ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 17. EUROPEAN ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 18. ASIA-PACIFIC ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 19. ASIA-PACIFIC ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 20. ASIA-PACIFIC ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 21. REST OF THE WORLD ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 22. REST OF THE WORLD ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 23. REST OF THE WORLD ESTROGEN AND PROGESTERONE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ESTROGEN AND PROGESTERONE MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 2. GLOBAL AGLEPRISTONE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 3. GLOBAL MIFEPRISTONE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 4. GLOBAL ASOPRISNIL MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 5. GLOBAL TELAPRISTONE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 6. GLOBAL ULIPRISTAL ACETATE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 7. GLOBAL ESTROGEN AND PROGESTERONE MARKET SHARE BY DISTRIBUTION CHANNEL, 2021 VS 2028 (%)
  • 8. GLOBAL ESTROGEN AND PROGESTERONE MARKET VIA PHARMACY SHARE BY REGION, 2021 VS 2028 (%)
  • 9. GLOBAL ESTROGEN AND PROGESTERONE MARKET VIA HOSPITAL AND CLINICS SHARE BY REGION, 2021 VS 2028 (%)
  • 10. GLOBAL ESTROGEN AND PROGESTERONE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 11. US ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 12. CANADA ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 13. UK ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 14. FRANCE ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 15. GERMANY ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 16. ITALY ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 17. SPAIN ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 18. REST OF EUROPE ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. INDIA ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. CHINA ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. JAPAN ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. REST OF ASIA-PACIFIC ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. REST OF THE WORLD ESTROGEN AND PROGESTERONE MARKET SIZE, 2021-2028 ($ MILLION)